- Home
- TEM
TEM
TEMPUS AI INC
as 11-15-2024 4:00pm EST
Stocks
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 7.0B | IPO Year: | 2024 |
| Target Price: | $55.00 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $22.89 - $79.49 | Next Earning Date: | 11-04-2024 |
| Revenue: | $640,442,000 | Revenue Growth: | 32.13% |
| Revenue Growth (this year): | 32.72% | Revenue Growth (next year): | 30.57% |
Latest TEMPUS AI INC News
TEM Breaking Stock News: Dive into TEM Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Tempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®
Business Wire
6 days ago
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
MT Newswires
6 days ago
Stifel Nicolaus Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $65 From $45
Business Wire
9 days ago
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
Insider Monkey
10 days ago
Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56
Business Wire
10 days ago
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test
Insider Monkey
10 days ago
Exciting Growth Potential Ahead for Tempus AI (TEM)
MedTech Dive
11 days ago
Tempus AI to buy genetic testing company for $600M
Compare TEM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEM TEMPUS AI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.